The landscape of dementia prognosis has evolved dramatically with the appearance of innovative biomarkers, which includes amyloid PET scans, tau imaging, and blood-based checks that could detect Alzheimer's pathology a long time before indications emerge. While these technological advancements signify extraordinary progress in understanding neurodegenerative disorders, they've not dim... https://robertq530ktc9.wikipublicity.com/user